The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
New Principles in Medicinal Organometallic Chemistry
Abstract
Hard-core drugs: Recent structural and spectroscopic studies demonstrate the versatility of organometallic drug candidates, for example, as novel protein kinase inhibitors and hormone-independent breast cancer prodrugs. The presence of a transition-metal center in such systems allows both the organization of ligands in 3D space (see picture) and the control of redox-activation processes in biological systems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cellular processing of platinum anticancer drugs
Wang, D., & Lippard, S. J. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1691 · Cited by 3,801
Cited by
Organometallic Anticancer Compounds
Gasser, G., Ott, I., & Metzler-Nolte, N. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm100020w · Cited by 1,624
Self-citationNew trends for metal complexes with anticancer activity
Bruijnincx, P. C., & Sadler, P. J. (2008) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2007.11.013 · Cited by 1,306
Occurrence, Biogenesis, and Synthesis of Biologically Active Carbazole Alkaloids
Schmidt, A. W., Reddy, K. R., & Knölker, H.-J. (2012) · Chemical Reviews · doi:10.1021/cr200447s · Cited by 1,243
Bioorganometallic chemistry—from teaching paradigms to medicinal applications
Hartinger, C. G., & Dyson, P. J. (2009) · Chem. Soc. Rev. · doi:10.1039/b707077m · Cited by 985
The medicinal chemistry of ferrocene and its derivatives
Patra, M., & Gasser, G. (2017) · Nature Reviews Chemistry · doi:10.1038/s41570-017-0066 · Cited by 609
Metadata
- Authors
- Schatzschneider, U., & Metzler‐Nolte, N.
- Venue
- Angewandte Chemie International Edition
- Publisher
- Wiley
- Published
- 2006-02-20
- Volume
- 45
- Issue
- 10
- Pages
- 1504-1507
- ISSN
- 1433-7851 (ISSN-L)
- 1521-3773
- OpenAlex
- W1991612914
- Cited by
- 194
- References
- 1
- FWCI
- 9.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.